Ward R A, Wathen R L, Williams T E, Harding G B
Kidney Int. 1987 Jul;32(1):129-35. doi: 10.1038/ki.1987.182.
We compared the effects of dialysate composition on changes in intermediary metabolites, acid-base balance, and potassium removal during hemodialysis. Patients were dialyzed against dialysates containing acetate or bicarbonate, each with or without glucose, in a four-way cross-over study. Dialysates containing acetate were associated with significant perturbations in intermediary metabolism, including increases in blood citrate, acetoacetate and beta-hydroxybutyrate and a decrease in pyruvate. In contrast, bicarbonate-containing dialysates caused minimal perturbations in intermediary metabolism. Addition of glucose to the dialysate decreased the changes in intermediary metabolites; however, the magnitude of this effect was less than that observed for the change from acetate to bicarbonate. Use of acetate also resulted in lower post-dialysis blood-concentrations of base equivalents than obtained with bicarbonate; this difference was unaffected by the presence or absence of glucose. Although pre- and post-dialysis potassium concentrations were unaffected by the dialysate formulation, total potassium removal was significantly greater when glucose was omitted from the dialysate. Our results suggest that both bicarbonate and glucose should be included in the dialysate, particularly for those patients whose capacity for metabolism may be limited because of highly efficient dialysis, intercurrent illness, or starvation. However, addition of glucose to the dialysate may require a reduction in dialysate potassium to maintain proper potassium homeostasis.
我们比较了透析液成分对血液透析期间中间代谢产物变化、酸碱平衡及钾清除的影响。在一项四交叉研究中,让患者分别使用含醋酸盐或碳酸氢盐的透析液进行透析,每种透析液又分为含葡萄糖和不含葡萄糖两种情况。含醋酸盐的透析液会导致中间代谢出现显著紊乱,包括血中柠檬酸、乙酰乙酸和β-羟丁酸增加,丙酮酸减少。相比之下,含碳酸氢盐的透析液对中间代谢的干扰极小。向透析液中添加葡萄糖可减少中间代谢产物的变化;然而,这种效果的程度小于从醋酸盐透析液改为碳酸氢盐透析液所观察到的变化。使用醋酸盐透析液还会导致透析后血液中碱当量浓度低于使用碳酸氢盐透析液时的浓度;这种差异不受葡萄糖存在与否的影响。尽管透析前后的钾浓度不受透析液配方的影响,但当透析液中不添加葡萄糖时,总的钾清除量显著增加。我们的结果表明,透析液中应同时包含碳酸氢盐和葡萄糖,特别是对于那些因高效透析、并发疾病或饥饿而代谢能力可能受限的患者。然而,向透析液中添加葡萄糖可能需要降低透析液中的钾含量,以维持适当的钾稳态。